Nature Communications (Oct 2017)
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance
Abstract
NADPH oxidase NOX4 has been linked to poor cancer survival. Here the authors show that NOX4 regulates drug resistance in renal cancer carcinoma by regulating PKM2 and that NOX4 activity is allosterically activated by reduced mitochondrial ATP levels thus coupling energy metabolism to drug resistance.